Kwangmeyung Kim Selected Research

Kwangmeyung Kim Research Topics

Disease

204	Neoplasms (Cancer) 04/2024 - 03/2006
11	Breast Neoplasms (Breast Cancer) 12/2020 - 05/2008
9	Thrombosis (Thrombus) 01/2021 - 06/2007
9	Rheumatoid Arthritis 06/2019 - 11/2008
8	Inflammation (Inflammations) 04/2022 - 10/2006
6	Atherosclerosis 01/2020 - 03/2010
6	Osteoarthritis 06/2019 - 09/2008
6	Melanoma (Melanoma, Malignant) 12/2013 - 03/2006
5	Stroke (Strokes) 01/2021 - 05/2013
5	Colonic Neoplasms (Colon Cancer) 12/2015 - 12/2009
5	Experimental Arthritis 10/2015 - 12/2010
4	Neoplasm Metastasis (Metastasis) 07/2022 - 06/2007
4	Ischemia 01/2021 - 09/2013
4	Hyperthermia 07/2020 - 05/2013
4	Arthritis (Polyarthritis) 06/2019 - 12/2011
3	Cardiotoxicity 03/2023 - 12/2010
3	Pancreatic Neoplasms (Pancreatic Cancer) 11/2022 - 04/2022
3	Hemorrhage 01/2017 - 12/2014

Drug/Important Bio-Agent (IBA)

51	glycol-chitosanIBA 10/2023 - 10/2007
33	Peptides (Polypeptides)IBA 03/2024 - 04/2008
25	Small Interfering RNA (siRNA)IBA 11/2022 - 12/2009
24	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2024 - 02/2010
21	GoldIBA 01/2024 - 12/2010
20	Hyaluronic Acid (Hyaluronan)IBA 11/2022 - 01/2010
19	Matrix Metalloproteinases (MMPs)IBA 01/2016 - 09/2008
17	ProdrugsIBA 03/2024 - 02/2015
15	Cathepsin BIBA 03/2024 - 01/2012
14	Proteins (Proteins, Gene)FDA Link 03/2024 - 06/2007
14	Therapeutic UsesIBA 10/2023 - 05/2008
14	Drug CarriersIBA 01/2023 - 04/2008
14	Coloring Agents (Dyes)IBA 07/2020 - 12/2009
12	Immune Checkpoint InhibitorsIBA 03/2024 - 04/2020
11	LigandsIBA 12/2017 - 11/2008
10	Photosensitizing Agents (Photosensitizers)IBA 04/2023 - 05/2009
10	MicellesIBA 03/2023 - 11/2007
9	Liposomes (Liposome)IBA 03/2024 - 12/2009
9	PolymersIBA 03/2023 - 10/2007
8	Antineoplastic Agents (Antineoplastics)IBA 06/2023 - 05/2009
8	1-phenyl-3,3-dimethyltriazene (PDT)IBA 04/2023 - 04/2011
8	Poloxamer (Poloxamer 407)IBA 10/2021 - 05/2010
8	CY5.5 cyanine dyeIBA 07/2020 - 10/2007
7	Heparin (Liquaemin)FDA LinkGeneric 12/2014 - 06/2007
6	AlbuminsIBA 01/2023 - 04/2011
6	Paclitaxel (Taxol)FDA LinkGeneric 03/2022 - 03/2006
6	Contrast MediaIBA 01/2019 - 01/2014
6	IntegrinsIBA 01/2017 - 04/2008
6	ChitosanIBA 11/2015 - 04/2010
5	AntigensIBA 04/2023 - 02/2015
5	CytokinesIBA 04/2022 - 02/2014
5	EnzymesIBA 04/2020 - 12/2009
5	AzidesIBA 01/2020 - 03/2014
5	Peptide Hydrolases (Proteases)FDA Link 06/2019 - 03/2010
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2017 - 12/2013
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2015 - 11/2008
5	Docetaxel (Taxotere)FDA Link 07/2014 - 10/2011
4	Silicon Dioxide (Silica)FDA LinkGeneric 01/2024 - 10/2011
4	Caspase 3 (Caspase-3)IBA 04/2022 - 02/2015
4	Dextran SulfateIBA 04/2022 - 01/2014
4	Human Serum Albumin FDA LinkGeneric 03/2022 - 04/2011
4	Oxygen (Dioxygen)IBA 01/2022 - 01/2018
4	Fluorescent Dyes (Fluorescent Probes)IBA 01/2020 - 07/2014
4	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2017 - 05/2013
4	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 11/2011 - 05/2008
3	CaspasesIBA 03/2024 - 02/2011
3	maleimideIBA 01/2023 - 12/2019
3	CollagenIBA 11/2022 - 10/2017
3	HydrogelsIBA 09/2022 - 10/2006
3	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2022 - 10/2016
3	phenylalanyl-arginyl-arginineIBA 10/2021 - 12/2020
3	Neoplasm Antigens (Tumor Antigens)IBA 06/2021 - 10/2016
3	ErbB Receptors (EGF Receptor)IBA 12/2020 - 12/2013
3	ferric oxide (iron oxide)IBA 07/2020 - 04/2011
3	Singlet OxygenIBA 12/2019 - 04/2011
3	Polysaccharides (Glycans)IBA 01/2017 - 11/2016
3	AcidsIBA 01/2017 - 06/2010
3	CopperIBA 10/2016 - 11/2012
3	Ferritins (Ferritin)IBA 10/2016 - 02/2011
3	DisulfidesIBA 11/2014 - 10/2011
3	CeramidesIBA 01/2014 - 10/2011
3	Ethylene Glycol (Monoethylene Glycol)IBA 06/2013 - 02/2010
3	protoporphyrin IXIBA 06/2011 - 05/2009
3	poly(beta-amino ester)IBA 06/2010 - 11/2007
3	monomethoxypolyethylene glycol (MPEG)IBA 06/2010 - 11/2007
2	Monoclonal AntibodiesIBA 03/2024 - 12/2013
2	Glucose (Dextrose)FDA LinkGeneric 03/2023 - 01/2017
2	snake venom protein C activatorIBA 01/2023 - 01/2023
2	Proteolysis Targeting ChimeraIBA 01/2023 - 01/2023
2	Serum AlbuminIBA 01/2023 - 12/2019
2	monomethyl auristatin EIBA 10/2022 - 04/2022

Therapy/Procedure

111	Therapeutics 03/2024 - 11/2007
21	Immunotherapy 04/2024 - 02/2015
17	Precision Medicine 05/2021 - 04/2011
16	Intravenous Injections 10/2022 - 10/2011
14	Photochemotherapy (Photodynamic Therapy) 04/2023 - 08/2010
13	Drug Therapy (Chemotherapy) 11/2022 - 12/2010
8	Intravenous Administration 02/2016 - 06/2007
7	Lasers (Laser) 01/2024 - 04/2011
7	Photothermal Therapy 01/2024 - 12/2010
3	RNAi Therapeutics 11/2022 - 08/2014
3	Microbubbles 10/2020 - 07/2015